Stocks vs. Options: Which generates better returns?
Plug in your stock idea to find options trades offering a potentially better ROI.
NEW TO OPTIONS?
Visit our New to Options page to learn more.
Find out more »
Related Symbols: AXUL
Partner
Offer
AXUL Stock Trades on OptionsHouse
$2.95 Flat-Rate Stock Trades. Open an Account Online Now!
01:38 PM Eastern Daylight Time, 03/15/2010 (MidnightTrader) — Auxilium Pharmaceuticals Inc. (AXUL) is down 4%, with most of the decline coming at the bell, after an analyst’s negative comments concerning sales of its drug Xiaflex.
Leerink Swann analyst Joseph Schwartz said doctors will be reluctant to use Xiaflex until reimbursement rates increase. He downgraded Auxilium shares to "market perform" from "outperform," and nailed the company with a near 50% cut in 2010 his revenue estimate for Xiaflex. The analyst also trimmed his price target to $35 per share from $40.
Schwartz said doctors want $456 per treatment cycle to use the drug. Last month, Auxilium said it expects doctors who use Xiaflex to be paid about $250 per treatment cycle.
Price: 32.95, Change: -1.46, Percent Change: -4.24
Higher returns with less capital. It’s called leverage and options have it—stocks don’t. Learn more:
Two Traders, One Strategy Steve and Jared take a look at risk management strategies on the OH platform.
Navigating OptionsHouse Get to know the OH platform and all the tools you have at your disposal.